FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321378101> ?p ?o ?g. }

• W4321378101 endingPage "166" @default.
• W4321378101 startingPage "161" @default.
• W4321378101 abstract "To discuss the efficacy and potential prognostic factors of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC).A retrospective study was conducted to analyze the medical history of patients (n=111) confirmed with advanced NSCLC in the Affiliated Hospital of Putian University from 2018 to 2020. All enrolled patients with adenocarcinoma (n=69), squamous cell carcinoma (n=28), and other types of lung cancer (n=14) were treated with the programmed death-ligand 1 (PD-1) inhibitors. They were divided into groups of PD-1 inhibitors, PD-1 inhibitors in combination with chemotherapy, and PD-1 inhibitors in combination with chemotherapy and angiogenesis inhibitors according to the treatment regimen. General clinical data of all patients were collected, and the Kaplan-Meier analysis was applied to estimate progression-free survival (PFS) and overall survival (OS). In addition, univariate and multivariate Cox regression analyses were performed to analyze prognostic factors associated with PFS and OS after treatment.Of 111 patients with advanced NSCLC treated with ICIs, 6 were fully responsive, 33 were partially responsive, 55 were stable, and 17 were progressive. There was no significant difference in objective response rate between the 3 groups. In the subgroup analysis according to the lines of therapy, the objective response rate of patients receiving first-line treatment was 46.7%, which was significantly higher than that of other line treatment groups ( P =0.014). The results of multivariate Cox regression analysis indicated that the history of hormone use (HR=1.593; P =0.033), second-line or further lines of therapy (HR=2.871; P <0.001), and high neutrophil/lymphocyte ratio (NLR; HR=1.498; P =0.045) were independent risk factors for PFS after immunotherapy for advanced NSCLC. And the history of hormone use (HR=1.518; P =0.015) and high NLR (HR=3.053; P =0.001) were as well the independent risk factors for OS after immunotherapy for advanced NSCLC.ICIs therapy clearly had a greater survival benefit in patients who received first-line therapy, had no history of hormone use, and showed low NLR after initial treatment. ICIs can be an effective treatment for advanced NSCLC." @default.
• W4321378101 created "2023-02-21" @default.
• W4321378101 creator A5009670560 @default.
• W4321378101 creator A5049209389 @default.
• W4321378101 creator A5070817876 @default.
• W4321378101 creator A5076837293 @default.
• W4321378101 date "2023-02-20" @default.
• W4321378101 modified "2023-10-15" @default.
• W4321378101 title "Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer" @default.
• W4321378101 cites W1989734503 @default.
• W4321378101 cites W2066671159 @default.
• W4321378101 cites W2078775732 @default.
• W4321378101 cites W2117692326 @default.
• W4321378101 cites W2138089710 @default.
• W4321378101 cites W2160982674 @default.
• W4321378101 cites W2166084034 @default.
• W4321378101 cites W2210073947 @default.
• W4321378101 cites W2527905628 @default.
• W4321378101 cites W2635951006 @default.
• W4321378101 cites W2760874344 @default.
• W4321378101 cites W2765831845 @default.
• W4321378101 cites W2775559698 @default.
• W4321378101 cites W2791304312 @default.
• W4321378101 cites W2886963239 @default.
• W4321378101 cites W2888599070 @default.
• W4321378101 cites W2889646458 @default.
• W4321378101 cites W2907929014 @default.
• W4321378101 cites W2925446385 @default.
• W4321378101 cites W2938929416 @default.
• W4321378101 cites W2967398918 @default.
• W4321378101 cites W3119005666 @default.
• W4321378101 cites W3128646645 @default.
• W4321378101 cites W4214578971 @default.
• W4321378101 doi "https://doi.org/10.1097/coc.0000000000000985" @default.
• W4321378101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36806256" @default.
• W4321378101 hasPublicationYear "2023" @default.
• W4321378101 type Work @default.
• W4321378101 citedByCount "1" @default.
• W4321378101 countsByYear W43213781012023 @default.
• W4321378101 crossrefType "journal-article" @default.
• W4321378101 hasAuthorship W4321378101A5009670560 @default.
• W4321378101 hasAuthorship W4321378101A5049209389 @default.
• W4321378101 hasAuthorship W4321378101A5070817876 @default.
• W4321378101 hasAuthorship W4321378101A5076837293 @default.
• W4321378101 hasConcept C121608353 @default.
• W4321378101 hasConcept C126322002 @default.
• W4321378101 hasConcept C143998085 @default.
• W4321378101 hasConcept C144301174 @default.
• W4321378101 hasConcept C167135981 @default.
• W4321378101 hasConcept C2776256026 @default.
• W4321378101 hasConcept C2776694085 @default.
• W4321378101 hasConcept C2776907518 @default.
• W4321378101 hasConcept C2781182431 @default.
• W4321378101 hasConcept C2781413609 @default.
• W4321378101 hasConcept C38180746 @default.
• W4321378101 hasConcept C50382708 @default.
• W4321378101 hasConcept C71924100 @default.
• W4321378101 hasConceptScore W4321378101C121608353 @default.
• W4321378101 hasConceptScore W4321378101C126322002 @default.
• W4321378101 hasConceptScore W4321378101C143998085 @default.
• W4321378101 hasConceptScore W4321378101C144301174 @default.
• W4321378101 hasConceptScore W4321378101C167135981 @default.
• W4321378101 hasConceptScore W4321378101C2776256026 @default.
• W4321378101 hasConceptScore W4321378101C2776694085 @default.
• W4321378101 hasConceptScore W4321378101C2776907518 @default.
• W4321378101 hasConceptScore W4321378101C2781182431 @default.
• W4321378101 hasConceptScore W4321378101C2781413609 @default.
• W4321378101 hasConceptScore W4321378101C38180746 @default.
• W4321378101 hasConceptScore W4321378101C50382708 @default.
• W4321378101 hasConceptScore W4321378101C71924100 @default.
• W4321378101 hasIssue "4" @default.
• W4321378101 hasLocation W43213781011 @default.
• W4321378101 hasLocation W43213781012 @default.
• W4321378101 hasOpenAccess W4321378101 @default.
• W4321378101 hasPrimaryLocation W43213781011 @default.
• W4321378101 hasRelatedWork W1975698825 @default.
• W4321378101 hasRelatedWork W1984291133 @default.
• W4321378101 hasRelatedWork W2092721488 @default.
• W4321378101 hasRelatedWork W2156078606 @default.
• W4321378101 hasRelatedWork W2411442805 @default.
• W4321378101 hasRelatedWork W2471405966 @default.
• W4321378101 hasRelatedWork W274490372 @default.
• W4321378101 hasRelatedWork W2995386125 @default.
• W4321378101 hasRelatedWork W3029464781 @default.
• W4321378101 hasRelatedWork W4210903696 @default.
• W4321378101 hasVolume "46" @default.
• W4321378101 isParatext "false" @default.
• W4321378101 isRetracted "false" @default.
• W4321378101 workType "article" @default.